SCHEMBL30558179

SCHEMBL30558179

NC(=O)CC[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ BLM P54132 1/20 0.49
▸ PMP22 Q01453 1/20 0.49
▸ PTGS1 P23219 1/20 0.48
▸ GSTK1 Q9Y2Q3 1/20 0.48
▸ NOD1 Q9Y239 6/20 0.47
▸ GLO1 Q04760 1/20 0.45
▸ DPP4 P27487 1/20 0.44
▸ DPP8 Q6V1X1 1/20 0.44
▸ DPP9 Q86TI2 1/20 0.44
▸ FNTA P49354 2/20 0.41
▸ FNTB P49356 2/20 0.41
▸ PGGT1B P53609 1/20 0.41
▸ CA2 P00918 3/20 0.40
▸ CA1 P00915 2/20 0.40
▸ FOLH1 Q04609 1/20 0.39
▸ RIMKLA Q8IXN7 1/20 0.39
▸ NAALAD2 Q9Y3Q0 1/20 0.39
▸ GNPAT O15228 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29670065 0.96 PTGS1 (0.48) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL29658148 0.91 KMT2A (0.46) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL11133652 0.90 PTGS1 (0.45) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL30292792 0.89 PTGS1 (0.52) PTGS1GSTK1NOD1GLO1DPP4
SCHEMBL30254935 0.89 FOLH1 (0.48) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL30563216 0.89 DPP4 (0.48) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL30785838 0.89 FOLH1 (0.48) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL30853510 0.88 NOD1 (0.45) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL31433265 0.87 FOLH1 (0.46) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL7614754 0.87 NOD1 (0.52) KMT2AALOX15BLMPMP22PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240041740-A1 SKIN PEEL COMPOSITIONS GLO PHARMA INC (US) 2024-02-08 — — US disclosed
US-20230270635-A1 METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS GLO PHARMA INC (US) 2023-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230270635-A1 METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS CUTA, GLA, LIPA KMT2A 3524/4885ALOX15 619/4885BLM 1629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback